Presentation Information
[P047]High agreement between in-house SYBR green-based real-time PCR targeting the RdRP gene and a commercial TaqMan probe-based for the detection of SARS-CoV-2 from clinical samples
○Muhareva Raekiansyah Raekiansyah1, Ratika Rahmasari2, Mya Myat Ngwe Tun1,3,4, Kouichi Morita1,3,5 (1. Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University (Japan), 2. Microbiology and Biotechnology Laboratory, Faculty of Pharmacy, Universitas Indonesia, Depok, West Java (Indonesia), 3. Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki (Japan), 4. Center for Vaccines and Therapeutic Antibodies for Emerging Infectious Diseases, Shimane University, Izumo (Japan), 5. DEJIMA Infectious Disease Research Alliance, Nagasaki University, Nagasaki (Japan))
Password required to view
Comment
To browse or post comments, you must log in.Log in